• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

West Nile bird vaccine looks promising

November 1, 2002
Stephanie Davis

Washington-The first round of trials to develop a West Nile vaccine for birds has shown a significant reduction in mortality in inoculated American crows, scientists report.

Washington-The first round of trials to develop a West Nile vaccine for birds has shown a significant reduction in mortality in inoculated American crows, scientists report.

The Centers for Disease Control and Prevention (CDC) in Fort Collins,Colo., carried out preliminary trials, which demonstrated a 60 percent increasein survival rates over unvaccinated birds in lab tests.

"We are very pleased with the initial tests and believe this couldbe an effective tool for protecting some of our most endangered birds suchas Mississippi sandhill cranes and California condors," says Dr. PattiBright, a veterinary epidemiologist.

Bright is director of the American Bird Conservancy's (ABC) Pesticidesand Birds Campaign. Leading efforts for the bird vaccine are the AmericanBird Conservancy (ABC), in partnership with the American Zoo and AquariumAssociation (AZA).

"We are now looking forward to conducting field trials at participatinginstitutions to see how the vaccine performs in real-world situations, outsideof the laboratory," says Bright. "We hope this will be a cross-speciesvaccine."

Real-life catastrophe

First discovered in an infected crow in Queens, N.Y., in 1999, the WestNile Virus' toll on both wild and captive birds has been enormous.

"At this point, it's too early in the game to know what the long-termimpacts are going to be on wild bird populations," says Bright.

Crows, blue jays and hawks have been among the worst hit, but 111 specieshave now been recorded as killed. At least tens of thousands of birds arethought to have been killed by the virus, according to estimates.

The American crow suffers close to 100 percent mortality rates in thewild when infected by West Nile Virus and so was chosen as the test speciesfor the vaccine trials. At the CDC lab, scientists noted a reduction inmortality rates of 60 percent by use of the new injectable recombinant DNAvaccine.

Advertisement

"We're hoping that since crows are so susceptible, if we're ableto get their mortality rate down, we'll do an even better job in other speciesthat are less susceptible to the disease," says Bright.

Down the road

The bird vaccine ultimately would be designed for birds that are in captivity,either companion animal birds or zoo-based birds. Eventually the goal wouldbe to reach endangered species programs or captive breeding programs.

The latest species to be considered for vaccine testing are geese andred-tailed hawks. The new study will actually challenge the birds with thevirus after they have been vaccinated.

Independent efforts

Concurrently, researchers at CDC, in collaboration with Colorado StateUniversity, United States Army Medical Research Institute for InfectiousDiseases, Harvard University and Temple University, are investigating themanufacture of an oral vaccine for use on wild bird populations. Recentsuccesses with injectable vaccines may lead one step closer to this goal.

As for the vaccine available for use in horses, although zoo officialshave tested its efficacy on birds, by and large they report it appears tohave little effect, if any, on avian species, with the exception of flamingosand black-footed penguins, says Bright.

Disney Wildlife Conservation Fund is primarily funding the bird vaccineproject. Additional supporters include the Dallas Zoo, Brookfield Zoo, FranklinPark Zoo, Houston Zoo and St. Louis Zoo.


Advertisement

Latest News

Viticus group seeks applications for veterinary boot camp scholarship

Unusual parasite strain kills 4 California sea otters

Q&A with a keynote: Jan Bellows, DVM, DAVDC, DABVP, FAVD

Evaluating liver enzyme elevation

View More Latest News
Advertisement